Chelating Agents. Chelators . Metal Chelating Agents . Agents, Chelating . Agents, Metal Chelating . Antagonists, Metal . Chelating Agents, Metal . Complexons . Metal Antagonists . Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. . 1.00
Complexism. Therapeutical approach that simultaneously combines various homeopathic remedies in the same bottle. These compounds are used for treating a particular illness without having been tested on healthy humans. . 0.64
Emtricitabine, Rilpivirine, Tenofovir Drug Combination. Complera . Emtricitabine Rilpivirine Tenofovir Drug Combination . Emtricitabine-Rilpivirine-Tenofovir Drug Combination . Combination, Emtricitabine-Rilpivirine-Tenofovir Drug . Drug Combination, Emtricitabine-Rilpivirine-Tenofovir . A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS. . 0.64
Complement System Proteins. Complement . Complement Protein . Hemolytic Complement . Complement, Hemolytic . Protein, Complement . Proteins, Complement . Proteins, Complement System . Complement Proteins . Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). . 0.59
Complement Membrane Attack Complex. C 5b-9 . C5b-8-poly-C9 . C5b-9 . Cytolytic Terminal Complement Complex . Terminal Complement Complex . C5b 8 poly C9 . Complement Complex C5b 9 . Complement Complex, Terminal . Complex, Terminal Complement . Membrane Attack Complex . Complement Complex C5b-9 . A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components (COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9) into the target membrane. The resultant C5b-8-poly-C9 is the "membrane attack complex" or MAC. . 0.58
Electron Transport Complex III. Coenzyme Q-Cytochrome-c Reductase . Coenzyme QH2-Cytochrome-c Reductase . Core I Protein, UCCreductase . Core I Protein, Ubiquinol-Cytochrome c Reductase . Core II Protein, UCCreductase . Core II Protein, Ubiquinol-Cytochrome c Reductase . Cytochrome b-c2 Oxidoreductase . Cytochrome bc1 . Dihydroubiquinone-Cytochrome-c Reductase . QH(2)-Cytochrome-c Reductase . QH(2)-Ferricytochrome-c Oxidoreductase . Ubihydroquinone-Cytochrome-c Reductase . Ubiquinol-Cytochrome c Reductase . Ubiquinone-Cytochrome b-c2 Oxidoreductase . Coenzyme Q Cytochrome c Reductase . Coenzyme QH2 Cytochrome c Reductase . Core I Protein, Ubiquinol Cytochrome c Reductase . Core II Protein, Ubiquinol Cytochrome c Reductase . Cytochrome b c2 Oxidoreductase . Dihydroubiquinone Cytochrome c Reductase . Reductase, Ubiquinol-Cytochrome c . Ubihydroquinone Cytochrome c Reductase . Ubiquinol Cytochrome c Reductase . Ubiquinone Cytochrome b c2 Oxidoreductase . Complex III . Cytochrome bc1 Complex . Ubiquinol-Cytochrome-c Reductase . A multisubunit enzyme complex that contains CYTOCHROME B GROUP; CYTOCHROME C1; and iron-sulfur centers. It catalyzes the oxidation of ubiquinol to UBIQUINONE, and transfers the electrons to CYTOCHROME C. In MITOCHONDRIA the redox reaction is coupled to the transport of PROTONS across the inner mitochondrial membrane. . 0.58
Pallister-Hall Syndrome. CAVE Complex . Cerebroacrovisceral Early Lethality Complex . Hall-Pallister Syndrome . Hypothalamic Hamartoblastoma Syndrome . Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly . CAVE Complices . Complex, CAVE . Complices, CAVE . Hall Pallister Syndrome . Hamartoblastoma Syndrome, Hypothalamic . Hamartoblastoma Syndromes, Hypothalamic . Hypothalamic Hamartoblastoma Syndromes . Pallister Hall Syndrome . Syndrome, Hall-Pallister . Syndrome, Hypothalamic Hamartoblastoma . Syndrome, Pallister-Hall . Syndromes, Hypothalamic Hamartoblastoma . A pleiotropic disorder of human development that comprises hypothalamic HAMARTOMA; central and postaxial POLYDACTYLY; bifid EPIGLOTTIS; ANAL ATRESIA; and renal and other abnormalities. This disorder is associated with FRAMESHIFT MUTATIONS in the GLI3 gene which encodes the GLI3 protein, a KRUPPEL-LIKE TRANSCRIPTION FACTORS family member. . 0.57
